期刊文献+

Targeting cancer stem cells in squamous cell carcinoma 被引量:2

原文传递
导出
摘要 Head and neck squamous cell carcinoma(HNSCC)is a highly aggressive tumor and the sixth most common cancer worldwide.Current treatment strategies for HNSCC are surgery,radiotherapy,chemotherapy,immunotherapy or combinatorial therapies.However,the overall 5-year survival rate of HNSCC patients remains at about 50%.Cancer stem cells(CSCs),a small population among tumor cells,are able to self-renew and differentiate into different tumor cell types in a hierarchical manner,similar to normal tissue.In HNSCC,CSCs are proposed to be responsible for tumor initiation,progression,metastasis,drug resistance,and recurrence.In this review,we discuss the molecular and cellular characteristics of CSCs in HNSCC.We summarize current approaches used in the literature for identification of HNSCC CSCs,and mechanisms required for CSC regulation.We also highlight the role of CSCs in treatment failure and therapeutic targeting options for eliminating CSCs in HNSCC.
出处 《Precision Clinical Medicine》 2019年第3期152-165,共14页 精准临床医学(英文)
基金 This work was supported by the National Institutes of Health(Grant No.:R01 DE15964)(C.Y.W).
  • 相关文献

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部